At Genetek Lifesciences, we are taking a bold step forward in our mission to deliver world-class healthcare solutions. Our upcoming EU-compliant manufacturing facility at MIHAN, Nagpur represents a new era of growth, quality, and global integration.

This state-of-the-art facility is being designed to meet the most stringent international regulatory standards, ensuring that every product manufactured aligns with European Union Good Manufacturing Practices (EU-GMP). Equipped with advanced technology, automated systems, and modern infrastructure, the facility will focus on producing high-quality formulations, sterile injectables, and contrast media for both domestic and international markets.

Located within the MIHAN (Multi-modal International Cargo Hub and Airport at Nagpur) Special Economic Zone, the site offers unmatched advantages in logistics, exports, and global connectivity. With direct access to international markets, this facility will strengthen our ability to serve partners worldwide with speed, efficiency, and reliability.

The new EU-compliant unit reflects more than an expansion of capacity; it embodies our commitment to innovation, compliance, and patient safety. It positions Genetek Lifesciences not only as a trusted partner in India but also as a significant player in the global pharmaceutical ecosystem.

As we prepare to bring this facility online, we remain guided by one vision: to make healthcare more accessible, reliable, and sustainable through continuous advancement in manufacturing excellence.